An Effective Assessment of Simvastatin-Induced Toxicity with NMR-Based Metabonomics Approach
2011

Assessing Simvastatin Toxicity with NMR Metabonomics

Sample size: 18 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yang Hye-ji, Choi Myung-Joo, Wen He, Kwon Hyuk Nam, Jung Kyung Hee, Hong Sang-Won, Kim Joon Mee, Hong Soon-Sun, Park Sunghyouk

Primary Institution: Inha University Hospital

Hypothesis

Can NMR-based metabonomics effectively evaluate simvastatin-induced toxicity?

Conclusion

The NMR-based metabonomics approach provides a non-invasive and effective way to evaluate simvastatin-induced toxicity.

Supporting Evidence

  • NMR analysis identified three new biological markers associated with simvastatin toxicity.
  • The metabonomics approach allowed for earlier detection of toxicity compared to conventional methods.
  • The study categorized post-treatment subjects into weak and high toxicity groups based on urine profiles.

Takeaway

This study shows that we can use urine samples to find out if simvastatin, a cholesterol medicine, is causing harm to the body without needing to do painful tests.

Methodology

NMR-based metabonomics analysis of urine samples was performed to evaluate simvastatin toxicity, comparing pre- and post-treatment groups.

Potential Biases

Potential bias in the selection of animal subjects and the interpretation of biochemical data.

Limitations

The study was limited to a specific animal model and may not fully represent human responses.

Participant Demographics

Female Wistar rats, 6 weeks old.

Statistical Information

P-Value

p<0.02 for AST, p<0.03 for ALT

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0016641

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication